More from the Company Monthly Newsletter July 2018
The month of July was marked by our first distribution agreement that was signed with Leib Medical Ltd. for the United Kingdom and Ireland, face-to-face meetings with potential distributors and an all-day meeting together with the General Assembly of Euro-HYP-1 in Copenhagen.
QuickCool and Leib Medical Ltd. signed the first distribution agreement at the office in Lund.
Leib Medical takes responsibility for launching, marketing and selling the QuickCool© SYSTEM as well as for service, maintenance and training of the same on the important Irish and British markets. With an already established network of customers and Key Opinion Leaders, complementary product portfolio, in combination with many years of experience within the field of MedTech and healthcare, Leib Medical is a most suitable partner on some of the most important markets in the world.
We are looking forward to many successful years together!
The European cooperation within the field of stroke started in August 2013 when one started to recruit patients to the clinical study called EuroHYP-1. It was completed on 1stof March this year. One included a total of 98 patients from 27 different hospitals across Europe. The purpose of the meeting in Copenhagen was to discuss the results of the study and discuss how the results shall be presented later this year. You may read more about EuroHYP-1 by clicking on the following link: https://www.eurohyp1.eu/
We both started and ended the month with face-to-face meetings with potential distributors in Europe.
Last week we launched our new logotype with a new, modern font. The white background of the logotype makes it easier for us to include it on printed material as well as on labels on our cooling device and packaging material for our Nasal Cooling Kits, for example.
We seized the opportunity to renew our homepage. The new structure facilitates the process of introducing new material and languages. The improvements will be introduced over the year. Should you wish to see our new, updated homepage, simply click on the following link: http://www.quickcool.se/
Everyone at QuickCool wishes you a nice and sunny summer!
On http://www.quickcool.se/en/home.html you may find more information about QuickCool and our solution in English.
Kind regards,
Fredrik
Fredrik Radencrantz
CEO
QuickCool AB
Ideon Science Park
Beta 6, Scheelevägen 17 - SE-223 70 Lund - Sweden
E-mail: fredrik.radencrantz@quickcool.se Web: www.quickcool.se
Mobile +46 (0)73 834 1188
Quickcool is a Swedish medical technology company, whose business concept is to save lives and prevent brain damage in acute ischemia (Inadequate blood supply to the brain) by developing and providing a unique and globally patented cooling system, the Quickcool SYSTEM. Quickcool is active in the fast-growing market, Targeted Temperature Management (TTM), for brain-protective cooling treatment of patients with e.g. acute cardiac arrest and stroke. QuickCool’s solution protects the brain by cooling in the nasal cavity and thus takes advantage of the innate heat exchanger in the nose. QuickCool’s Intranasal method offers gentle and uninterrupted cooling treatment for sedated patients. Quickcool is listed on Spotlight Stock Market and conducts its business at Ideon Science Park in Lund. For more Information, please refer to www.quickcool.se
Tags: